Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia.
about
Systematic reviews of complementary therapies - an annotated bibliography. Part 2: herbal medicineEvidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasiaSerenoa repens for benign prostatic hyperplasiaQianliening capsule inhibits benign prostatic hyperplasia angiogenesis via the HIF-1α signaling pathway.Herbs for benign prostatic hyperplasia.Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract.The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia.Saw palmetto and benign prostatic hyperplasia.Preventing diseases of the prostate in the elderly using hormones and nutriceuticals.Pharmacological effects of saw palmetto extract in the lower urinary tractThe evaluation and treatment of nocturia: a consensus statement.The New England Research Institutes, Inc. (NERI) Nocturia Advisory Conference 2012: focus on outcomes of therapy.Qianliening capsule () inhibits human prostate cell growth via induction of mitochondrion-dependent cell apoptosis.Qianliening capsule treats benign prostatic hyperplasia via suppression of the EGF/STAT3 signaling pathway.82-year-old man with bilateral leg swelling.Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia.
P2860
Q24802805-295F8027-4468-4B04-B777-C1E702FBC088Q28077954-EC6B451B-C81E-493B-AB66-1DC402B89AADQ28215754-5A42CCE9-65BD-4106-A11F-EEEBE8C1CA74Q33769561-257E0C91-7799-41CF-96F9-0E7D1808178FQ34797013-4A8C5C38-767E-41B4-AA89-F0C3B8C71DDFQ35854081-033BA455-F35B-41CE-BF44-4E102F76532AQ35855002-E7276E20-C5E9-46E5-AA7C-85E42F5A3088Q35877386-D0E8B413-C43E-4327-A71D-E301280889A3Q36021075-5C292F0C-B875-4CF2-AF31-178D50C99381Q37406930-4B2F35AC-CCD0-4A55-A648-41319C1BE96AQ37890031-C966F4FC-1E29-4F69-A066-9B5A32747744Q38077543-2429FC39-EB2C-425A-9887-7995B39BE2C5Q39255492-207084A5-498C-4AD4-8B86-6FCE8418C74DQ41484907-E3A3325A-56C4-4C14-8FD1-D3AB42319A73Q42434153-99D97152-0269-418A-B90A-6805BF61AE53Q44969928-4BDD9D6D-72A0-46EB-AC63-7DEAA66805F9Q53288113-389B5285-689C-4853-A101-1C502798BAB9
P2860
Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Meta-analysis of clinical tria ...... benign prostatic hyperplasia.
@ast
Meta-analysis of clinical tria ...... benign prostatic hyperplasia.
@en
type
label
Meta-analysis of clinical tria ...... benign prostatic hyperplasia.
@ast
Meta-analysis of clinical tria ...... benign prostatic hyperplasia.
@en
prefLabel
Meta-analysis of clinical tria ...... benign prostatic hyperplasia.
@ast
Meta-analysis of clinical tria ...... benign prostatic hyperplasia.
@en
P2093
P1433
P1476
Meta-analysis of clinical tria ...... benign prostatic hyperplasia.
@en
P2093
P304
P356
10.1016/S0090-4295(99)00593-2
P407
P50
P577
2000-04-01T00:00:00Z